SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-060869
Filing Date
2020-03-04
Accepted
2020-03-04 07:00:32
Documents
3
Period of Report
2020-03-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d795443d8k.htm 8-K 18408
2 EX-99.1 d795443dex991.htm EX-99.1 100933
3 GRAPHIC g795443dsp005.jpg GRAPHIC 8205
  Complete submission text file 0001193125-20-060869.txt   131859
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 (484) 395-2400
Recro Pharma, Inc. (Filer) CIK: 0001588972 (see all company filings)

IRS No.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36329 | Film No.: 20685661
SIC: 2834 Pharmaceutical Preparations